Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Shareholders' Equity - Schedule of Company's Option Activity (Details)

v3.26.1
Shareholders' Equity - Schedule of Company's Option Activity (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2025
Schedule of Weighted Average Exercise Prices Share Options [Abstract]    
Number of options, Grants (in Shares)   8,000
Weighted average exercise price, Grants   $ 16.01
Weighted average remaining contractual terms, Grants   10 years
Number of options, expired   77
Weighted average exercise price, expired  
Weighted average remaining contractual terms, expired  
Number of options, Ending (in Shares) 41,610 49,533
Weighted average exercise price, Ending $ 90 $ 87.31
Weighted average remaining contractual terms 7 years 1 month 6 days 6 years 7 months 6 days
Aggregate intrinsic value, Ending (in Dollars)
Number of options, Vested and expected to vest (in Shares)   49,533
Weighted average exercise price, Vested and expected to vest   $ 87.31
Weighted average remaining contractual terms, Vested and expected to vest   6 years 7 months 6 days
Aggregate intrinsic value, Vested and expected to vest (in Dollars)  
Number of options, Exercisable (in Shares)   25,497
Weighted average exercise price, Exercisable   $ 143.98
Weighted average remaining contractual terms, Exercisable   5 years 8 months 12 days
Aggregate intrinsic value, Exercisable (in Dollars)